• Profile
Close

High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females

The Journal of Infectious Diseases Feb 12, 2018

Donken R, et al. - Researchers here determined the vaccine effectiveness (VE) of the bivalent HPV-vaccine against incident and 12-month persistent infections up to six years post-vaccination. In this population-based cohort study, findings revealed nearly full protection against vaccine-type persistent infections and significant cross-protection to non-vaccine types. Findings, hereby, confirmed the effectiveness of the bivalent HPV vaccine as estimated in trials. No indications for waning were identified up to six years post-vaccination.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay